BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inoue K, Nakane Y, Iiyama H, Sato M, Kanbara T, Nakai K, Okumura S, Yamamichi K, Hioki K. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol. 2002;9:27-34. [PMID: 11829427 DOI: 10.1245/aso.2002.9.1.27] [Cited by in Crossref: 174] [Cited by in F6Publishing: 177] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Yip J, Orlov S, Orlov D, Vaisman A, Hernández KG, Etarsky D, Kak I, Parvinnejad N, Freeman JL, Walfish PG. Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence. Head Neck 2013;35:592-8. [DOI: 10.1002/hed.23047] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
2 Overman MJ, Hu CY, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116:5374-5382. [PMID: 20715162 DOI: 10.1002/cncr.25324] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
3 El Hanafy E, El Nakeeb A, Ezzat H, Hamdy E, Atif E, Kandil T, Fouad A, Wahab MA, Monier A. How does epidemiological and clinicopathological features affect survival after gastrectomy for gastric cancer patients-single Egyptian center experience. World J Gastrointest Surg 2016; 8(6): 444-451 [PMID: 27358677 DOI: 10.4240/wjgs.v8.i6.444] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Ausborn NL, Wang T, Wentz SC, Washington MK, Merchant NB, Zhao Z, Shyr Y, Chakravarthy AB, Xia F. 53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19-9 in pancreatic adenocarcinoma. BMC Cancer 2013;13:155. [PMID: 23530749 DOI: 10.1186/1471-2407-13-155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
5 Zhu C, Wu XZ. Proposal of new classification for stage III breast cancer on the number and ratio of metastatic lymph nodes. J Surg Oncol 2012;106:696-702. [PMID: 22488301 DOI: 10.1002/jso.23118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Deng J, Liang H, Zhang R, Sun D, Pan Y, Zhang L, Hao X. Clinicopathologic characteristics and outcomes of surgery of middle-third gastric cancer. Tumour Biol 2012;33:2091-8. [PMID: 22869239 DOI: 10.1007/s13277-012-0468-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Attaallah W, Gunal O, Manukyan M, Ozden G, Yegen C. Prognostic impact of the metastatic lymph node ratio on survival in rectal cancer. Ann Coloproctol. 2013;29:100-105. [PMID: 23862127 DOI: 10.3393/ac.2013.29.3.100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
8 Deng J, Liang H, Sun D, Pan Y, Liu Y, Wang D. Extended lymphadenectomy improvement of overall survival of gastric cancer patients with perigastric node metastasis. Langenbecks Arch Surg. 2011;396:615-623. [PMID: 21380618 DOI: 10.1007/s00423-011-0753-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
9 Douglass HO, Hundahl SA, Macdonald JS, Khatri VP. Gastric cancer: D2 dissection or low Maruyama Index-based surgery--a debate. Surg Oncol Clin N Am. 2007;16:133-155. [PMID: 17336241 DOI: 10.1016/j.soc.2006.10.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
10 Ding YB, Chen GY, Xia JG, Zang XW, Yang HY, Yang L, Liu YX. Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of gastric carcinoma in surgically-treated patients. World J Gastroenterol 2004; 10(2): 182-185 [PMID: 14716818 DOI: 10.3748/wjg.v10.i2.182] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
11 Hou Y, Wang X, Chen J. Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer. World J Surg Oncol 2018;16:198. [PMID: 30286762 DOI: 10.1186/s12957-018-1504-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
12 Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706-8712. [PMID: 16314630 DOI: 10.1200/jco.2005.02.8852] [Cited by in Crossref: 347] [Cited by in F6Publishing: 160] [Article Influence: 21.7] [Reference Citation Analysis]
13 Liu ZQ, Xiao ZW, Luo GP, Liu L, Liu C, Xu J, Long J, Ni QX, Yu XJ. Effect of the number of positive lymph nodes and lymph node ratio on prognosis of patients after resection of pancreatic adenocarcinoma. Hepatobiliary Pancreat Dis Int 2014;13:634-41. [PMID: 25475867 DOI: 10.1016/s1499-3872(14)60264-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
14 Pyo J, Kim NY, Son BK, Chung KH. Prognostic Implication of pN Stage Subdivision Using Metastatic Lymph Node Ratio in Resected Pancreatic Ductal Adenocarcinoma. Int J Surg Pathol 2020;28:245-51. [DOI: 10.1177/1066896919886057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011;81:1328-1335. [PMID: 20934270 DOI: 10.1016/j.ijrobp.2010.07.1993] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 4.3] [Reference Citation Analysis]
16 Ren H, Zhu J, Yu H, Bazhin AV, Westphalen CB, Renz BW, Jacob SN, Lampert C, Werner J, Angele MK, Bösch F. Angiogenesis-Related Gene Expression Signatures Predicting Prognosis in Gastric Cancer Patients. Cancers (Basel) 2020;12:E3685. [PMID: 33302481 DOI: 10.3390/cancers12123685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wang X, Wan F, Pan J, Yu G, Chen Y, Wang J. Prognostic value of the ratio of metastatic lymph nodes in gastric cancer: An analysis based on a Chinese population. J Surg Oncol 2009;99:329-34. [DOI: 10.1002/jso.21247] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
18 Wang Y, Huang CM, Wang JB, Zheng CH, Li P, Xie JW, Lin JX, Lu J. Survival and surgical outcomes of cardiac cancer of the remnant stomach in comparison with primary cardiac cancer. World J Surg Oncol 2014;12:21. [PMID: 24468299 DOI: 10.1186/1477-7819-12-21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
19 La Torre M, Cavallini M, Ramacciato G, Cosenza G, Rossi Del Monte S, Nigri G, Ferri M, Mercantini P, Ziparo V. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis. J Surg Oncol. 2011;104:629-633. [PMID: 21713779 DOI: 10.1002/jso.22013] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.8] [Reference Citation Analysis]
20 Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby DA, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM. Prognostic Performance of Different Lymph Node Staging Systems After Curative Intent Resection for Gastric Adenocarcinoma. Ann Surg. 2015;262:991-998. [PMID: 25563867 DOI: 10.1097/sla.0000000000001040] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
21 Schaefer N, Sinning C, Standop J, Overhaus M, Hirner A, Wolff M. Treatment and prognosis of gastric stump carcinoma in comparison with primary proximal gastric cancer. Am J Surg. 2007;194:63-67. [PMID: 17560911 DOI: 10.1016/j.amjsurg.2006.12.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
22 Berger AC, Fierro M, Kairys JC, Berd D, Sato T, Andrel J, Hyslop T, Mastrangelo MJ. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma: Lymph Node Ratio in Stage III Melanoma. J Surg Oncol 2012;105:15-20. [DOI: 10.1002/jso.22051] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
23 Yu JW, Wu JG, Zheng LH, Zhang B, Ni XC, Li XQ, Jiang BJ. Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma. J Exp Clin Cancer Res. 2009;28:55. [PMID: 19393100 DOI: 10.1186/1756-9966-28-55] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
24 Aurello P, Catracchia V, Petrucciani N, D'angelo F, Leonardo G, Picchetto A, Antolino L, Magistri P, Terrenato I, Lauro A, Ramacciato G. What is the Role of Nodal Ratio as a Prognostic Factor for Gastric Cancer Nowadays? Comparison with New TNM Staging System and Analysis According to the Number of Resected Nodes. The American Surgeon 2013;79:483-91. [DOI: 10.1177/000313481307900523] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
25 Bilici A, Seker M, Ustaalioglu BB, Yilmaz B, Doventas A, Salepci T, Gumus M. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Med Oncol. 2010;27:975-984. [PMID: 19885750 DOI: 10.1007/s12032-009-9319-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
26 Zhang BY, Yuan J, Cui ZS, Li ZW, Li XH, Lu YY. Evaluation of the prognostic value of the metastatic lymph node ratio for gastric cancer. Am J Surg. 2014;207:555-565. [PMID: 24124661 DOI: 10.1016/j.amjsurg.2013.05.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
27 Wong KP, Poon JTC, Fan JKM, Law WL. Prognostic value of lymph node ratio in stage III colorectal cancer: Lymph node ratio in stage III colorectal cancer. Colorectal Disease 2011;13:1116-22. [DOI: 10.1111/j.1463-1318.2010.02435.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
28 Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol. 2008;97:132-135. [PMID: 17979134 DOI: 10.1002/jso.20929] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
29 Akagi T, Shiraishi N, Kitano S. Lymph node metastasis of gastric cancer. Cancers (Basel). 2011;3:2141-2159. [PMID: 24212800 DOI: 10.3390/cancers3022141] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
30 Rocha FTR, Lourenço LG, Jucá MJ, Leal AT, Paz AMDCD. Expressão da proteína P53 no adenocarcinoma gástrico: correlação clínica, anatomopatológica e significância prognostica. Rev Col Bras Cir 2004;31:186-93. [DOI: 10.1590/s0100-69912004000300008] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
31 Jiang S, Zhao L, Xie C, Su H, Yan Y. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2020;11:402. [PMID: 32733379 DOI: 10.3389/fendo.2020.00402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Deng J, Liang H, Sun D, Pan Y. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection. J Surg Res. 2010;161:47-53. [PMID: 19783008 DOI: 10.1016/j.jss.2008.12.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
33 Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. Eur J Surg Oncol. 2008;34:159-165. [PMID: 17566691 DOI: 10.1016/j.ejso.2007.04.018] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 5.1] [Reference Citation Analysis]
34 Wang J, Dang P, Raut CP, Pandalai PK, Maduekwe UN, Rattner DW, Lauwers GY, Yoon SS. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database. Ann Surg. 2012;255:478-485. [PMID: 22330040 DOI: 10.1097/sla.0b013e31824857e2] [Cited by in Crossref: 137] [Cited by in F6Publishing: 77] [Article Influence: 13.7] [Reference Citation Analysis]
35 Díaz Del Arco C, Estrada Muñoz L, Sánchez Pernaute A, Ortega Medina L, García Gómez de Las Heras S, García Martínez R, Fernández Aceñero MJ. Towards standardization of lymph-node ratio classifications: Validation and comparison of different lymph node ratio classifications for predicting prognosis of patients with resected gastric cancer. Ann Diagn Pathol 2021;52:151738. [PMID: 33865185 DOI: 10.1016/j.anndiagpath.2021.151738] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 Liao C, Hsueh C, Lee L, Lin C, Fan K, Wang H, Huang S, Chen I, Kang C, Ng S, Tsao C, Huang Y, Yen T. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy. Oral Oncology 2012;48:329-36. [DOI: 10.1016/j.oraloncology.2011.10.017] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 7.1] [Reference Citation Analysis]
37 Tong LL, Gao P, Wang ZN, Song YX, Xu YY, Sun Z, Xing CZ, Wang X, Xu HM. Can lymph node ratio take the place of pN categories in the UICC/AJCC TNM classification system for colorectal cancer? Ann Surg Oncol. 2011;18:2453-2460. [PMID: 21455596 DOI: 10.1245/s10434-011-1687-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
38 Nakamura K, Nabeshima K, Makuuchi H, Ogoshi K. Prognostic significance of morphological distribution of metastatic foci in lymph nodes with gastric cancer. Dig Surg 2011;28:309-14. [PMID: 21921632 DOI: 10.1159/000327726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzoni G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007;245:543-52. [PMID: 17414602 DOI: 10.1097/01.sla.0000250423.43436.e1] [Cited by in Crossref: 254] [Cited by in F6Publishing: 262] [Article Influence: 16.9] [Reference Citation Analysis]
40 Oshiro Y, Sasaki R, Kobayashi A, Murata S, Fukunaga K, Kondo T, Oda T, Ohkohchi N. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol. 2011;37:60-64. [PMID: 21094016 DOI: 10.1016/j.ejso.2010.10.011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
41 Smith DD, Nelson RA, Schwarz RE. A comparison of five competing lymph node staging schemes in a cohort of resectable gastric cancer patients. Ann Surg Oncol. 2014;21:875-882. [PMID: 24242677 DOI: 10.1245/s10434-013-3356-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
42 Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257:718-725. [PMID: 23407295 DOI: 10.1097/sla.0b013e3182822277] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 9.4] [Reference Citation Analysis]
43 Yu JX, Li Y. The staging system of metastatic lymph node ratio in gastric cancer. Clin Oncol (R Coll Radiol). 2007;19:269-270. [PMID: 17433973 DOI: 10.1016/j.clon.2007.02.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
44 Wohnrath DR, Araujo RLC. Positive node-ratio in curative-intent treatment for gastric cancer is a strong independent prognostic factor for 5-year overall survival. J Surg Oncol 2020;121:777-83. [PMID: 31691299 DOI: 10.1002/jso.25755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
45 Lee SM, Shin JS, Choi HJ, Park KJ, Roh YH, Kwon HC, Roh MS, Lee HS, Kim C. Prognostic implication of metastatic lymph node ratio in node-positive rectal cancer. J Korean Surg Soc 2011;80:260-6. [PMID: 22066045 DOI: 10.4174/jkss.2011.80.4.260] [Reference Citation Analysis]
46 Pyo JS, Sohn JH, Chang K. Prognostic Role of Metastatic Lymph Node Ratio in Papillary Thyroid Carcinoma. J Pathol Transl Med 2018;52:331-8. [PMID: 30157618 DOI: 10.4132/jptm.2018.08.07] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
47 Costa Junior WL, Coimbra FJ, Batista TP, Ribeiro HS, Diniz AL. Evaluation of N-ratio in selecting patients for adjuvant chemoradiotherapy after d2-gastrectomy. Arq Gastroenterol 2013;50:257-63. [PMID: 24474226 DOI: 10.1590/S0004-28032013000400004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Cozzaglio L, Doci R, Celotti S, Roncalli M, Gennari L. Gastric Cancer: Extent of Lymph Node Dissection and Requirements for a Correct Staging. Tumori 2004;90:467-72. [DOI: 10.1177/030089160409000505] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
49 Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618. [PMID: 17462460 DOI: 10.1016/j.surg.2006.12.013] [Cited by in Crossref: 315] [Cited by in F6Publishing: 301] [Article Influence: 21.0] [Reference Citation Analysis]
50 Fukuda N, Sugiyama Y, Midorikawa A, Mushiake H. Prognostic significance of the metastatic lymph node ratio in gastric cancer patients. World J Surg 2009;33:2378-82. [PMID: 19760318 DOI: 10.1007/s00268-009-0205-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
51 Smith RA, Bosonnet L, Ghaneh P, Raraty M, Sutton R, Campbell F, Neoptolemos JP. Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma. Dig Surg. 2008;25:226-232. [PMID: 18577869 DOI: 10.1159/000140961] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 4.5] [Reference Citation Analysis]
52 Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer. Ann Thorac Surg. 2007;83:1265-1272. [PMID: 17383324 DOI: 10.1016/j.athoracsur.2006.12.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
53 Binquet C, Abrahamowicz M, Mahboubi A, Jooste V, Faivre J, Bonithon-kopp C, Quantin C. Empirical study of the dependence of the results of multivariable flexible survival analyses on model selection strategy. Statist Med 2008;27:6470-88. [DOI: 10.1002/sim.3447] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
54 Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS, Lin JK, Chang SC. The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg 2013;37:1927-33. [PMID: 23609344 DOI: 10.1007/s00268-013-2051-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
55 Rausei S, Dionigi G, Ruspi L, Proserpio I, Galli F, Tirotta F, Frattini F, Rovera F, Boni L, Pinotti G, Dionigi R. Lymph node staging in gastric cancer: new criteria, old problems. Int J Surg 2013;11 Suppl 1:S90-4. [PMID: 24380563 DOI: 10.1016/S1743-9191(13)60025-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
56 Park IJ, Choi GS, Jun SH. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio. J Surg Oncol. 2009;100:240-243. [PMID: 19330780 DOI: 10.1002/jso.21273] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
57 Sun Z, Xu Y, Li de M, Wang ZN, Zhu GL, Huang BJ, Li K, Xu HM. Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer. 2010;116:2571-2580. [PMID: 20336791 DOI: 10.1002/cncr.24989] [Cited by in Crossref: 96] [Cited by in F6Publishing: 113] [Article Influence: 8.0] [Reference Citation Analysis]
58 Li C, Xu F, Huang Q, Han D, Zheng S, Wu W, Zhao F, Feng X, Lyu J. Nomograms for Differentiated Thyroid Carcinoma Patients Based on the Eighth AJCC Staging and Competing Risks Model. JNCI Cancer Spectr 2021;5:pkab038. [PMID: 34159295 DOI: 10.1093/jncics/pkab038] [Reference Citation Analysis]
59 Shin K, Park SJ, Lee J, Park CH, Song KY, Lee HH, Seo HS, Jung YJ, Park JM, Lee SH, Roh SY, Kim IH. Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage. BMC Cancer 2019;19:1232. [PMID: 31852475 DOI: 10.1186/s12885-019-6433-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
60 Kim Y, Squires MH, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, Kooby DA, Worhunsky DJ, Jin LX, Hawkins WG, Acher AW, Cho CS, Saunders N, Levine EA, Schmidt CR, Maithel SK, Pawlik TM. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy. Surgery 2017;162:285-94. [PMID: 28578142 DOI: 10.1016/j.surg.2017.03.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
61 Lee SR, Kim HO, Son BH, Shin JH, Yoo CH. Prognostic significance of the metastatic lymph node ratio in patients with gastric cancer. World J Surg. 2012;36:1096-1101. [PMID: 22382768 DOI: 10.1007/s00268-012-1520-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
62 Qian J, Qian Y, Wang J, Gu B, Pei D, He S, Zhu F, Røe OD, Xu J, Liu L, Gu Y, Guo R, Yin Y, Shu Y, Chen X. A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy. Drug Des Devel Ther 2016;10:241-58. [PMID: 26966350 DOI: 10.2147/DDDT.S88743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
63 Deng J, Liang H. D2 lymphadenectomy in gastric cancer surgery. Clin Oncol Cancer Res 2009;6:162-8. [DOI: 10.1007/s11805-009-0162-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Sylvie L, Susanne B, Katja O. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Recent Results Cancer Res 2012;196:269-89. [PMID: 23129380 DOI: 10.1007/978-3-642-31629-6_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
65 Nakamura K, Ozaki N, Yamada T, Hata T, Sugimoto S, Hikino H, Kanazawa A, Tokuka A, Nagaoka S. Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery. 2005;137:511-517. [PMID: 15855922 DOI: 10.1016/j.surg.2005.01.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
66 Bouché O, Ychou M, Burtin P, Bedenne L, Ducreux M, Lebreton G, Baulieux J, Nordlinger B, Martin C, Seitz JF. Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801). Ann Oncol. 2005;16:1488-1497. [PMID: 15939717 DOI: 10.1093/annonc/mdi270] [Cited by in Crossref: 108] [Cited by in F6Publishing: 97] [Article Influence: 6.4] [Reference Citation Analysis]
67 Ceelen W, Van Nieuwenhove Y, Pattyn P. Prognostic value of the lymph node ratio in stage III colorectal cancer: a systematic review. Ann Surg Oncol 2010;17:2847-55. [PMID: 20559741 DOI: 10.1245/s10434-010-1158-1] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 10.3] [Reference Citation Analysis]
68 Park YH, Lee JI, Park JK, Jo HJ, Kang WK, An CH. Clinical Significance of Lymph Node Ratio in Stage III Colorectal Cancer. J Korean Soc Coloproctol 2011;27:260-5. [PMID: 22102977 DOI: 10.3393/jksc.2011.27.5.260] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
69 Kim JY, Chung SM, Choi BO, Lee IK, An CH, Won JM, Ryu MR. Prognostic significance of the lymph node ratio regarding recurrence and survival in rectal cancer patients treated with postoperative chemoradiotherapy. Gut Liver 2012;6:203-9. [PMID: 22570749 DOI: 10.5009/gnl.2012.6.2.203] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
70 Takeuchi H, Kitagawa Y. Is lymphadenectomy a predictor or savior for patients with gastric cancer? Ann Surg Oncol. 2010;17:1257-1258. [PMID: 20140527 DOI: 10.1245/s10434-010-0942-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
71 Kulig J, Sierzega M, Kolodziejczyk P, Popiela T. Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. British Journal of Surgery 2009;96:910-8. [DOI: 10.1002/bjs.6653] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
72 Danko ME, Bennett KM, Zhai J, Marks JR, Olson JA. Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up. Journal of the American College of Surgeons 2010;210:797-805.e1. [DOI: 10.1016/j.jamcollsurg.2010.02.045] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
73 Mocellin S, Pasquali S, Riccardo Rossi C, Nitti D. Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: A population-based study of 8,177 cases. Surgery 2011;150:83-90. [DOI: 10.1016/j.surg.2011.02.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
74 Wang J, Hassett JM, Dayton MT, Kulaylat MN. The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg. 2008;12:1790-1796. [PMID: 18709510 DOI: 10.1007/s11605-008-0651-3] [Cited by in Crossref: 73] [Cited by in F6Publishing: 83] [Article Influence: 5.2] [Reference Citation Analysis]
75 Li Z, Cen H. Construction of a nomogram for the prediction of prognosis in patients with resectable gastric cancer undergoing fewer than sixteen lymph node biopsies. Onco Targets Ther 2019;12:7415-28. [PMID: 31686848 DOI: 10.2147/OTT.S216086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
76 Li J, Li X, Gu J, Ma X, Xue F. A competing-risks nomogram for predicting probability of death from CRC in Chinese Han patients with Stage I-III CRC. Jpn J Clin Oncol 2018;48:1088-95. [PMID: 30257010 DOI: 10.1093/jjco/hyy136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
77 Matsuguma H, Oki I, Nakahara R, Ohata N, Igarashi S, Mori K, Endo S, Yokoi K. Proposal of new nodal classifications for non-small-cell lung cancer based on the number and ratio of metastatic lymph nodes. Eur J Cardiothorac Surg 2012;41:19-24. [PMID: 21620720 DOI: 10.1016/j.ejcts.2011.04.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
78 Deng JY, Liang H, Sun D, Zhan HJ, Wang XN. The most appropriate category of metastatic lymph nodes to evaluate overall survival of gastric cancer following curative resection. J Surg Oncol. 2008;98:343-348. [PMID: 18668672 DOI: 10.1002/jso.21119] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
79 Aurello P, D'angelo F, Rossi S, Bellagamba R, Cicchini C, Nigri G, Ercolani G, De Angelis R, Ramacciato G. Classification of Lymph Node Metastases from Gastric Cancer: Comparison between N-Site and N-Number Systems. Our Experience and Review of the Literature. The American Surgeon 2007;73:359-66. [DOI: 10.1177/000313480707300410] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
80 Mahdi H, Thrall M, Kumar S, Hanna R, Seward S, Lockhart D, Morris RT, Swensen R, Munkarah AR. The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients. J Surg Oncol 2011;103:724-9. [PMID: 21241015 DOI: 10.1002/jso.21869] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
81 Chin C, Wang J, Yeh C, Kuo Y, Huang W, Yeh C. Metastatic lymph node ratio is a more precise predictor of prognosis than number of lymph node metastases in stage III colon cancer. Int J Colorectal Dis 2009;24:1297-302. [DOI: 10.1007/s00384-009-0738-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
82 Nari GA, Palacios OG, Lopez-ben S, Albiol M, Falgueras L, Castro-gutierrez E, Figueras J. Colangiocarcinoma hiliar: el número de ganglios positivos y la relación ganglios positivos/ganglios totales son un factor pronóstico importante de supervivencia. Cirugía Española 2014;92:247-53. [DOI: 10.1016/j.ciresp.2013.07.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
83 Bouliaris K, Rachiotis G, Diamantis A, Christodoulidis G, Polychronopoulou E, Tepetes K. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system. European Journal of Surgical Oncology (EJSO) 2017;43:1350-6. [DOI: 10.1016/j.ejso.2017.03.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
84 Cidón EU. Gastric cancer and the search for a good prognostic classification: a challenge. Clin Exp Gastroenterol 2010;3:113-6. [PMID: 21694854 DOI: 10.2147/ceg.s11929] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
85 Kunisaki C, Makino H, Akiyama H, Otsuka Y, Ono HA, Kosaka T, Takagawa R, Nagahori Y, Takahashi M, Kito F. Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg. 2008;12:542-549. [PMID: 17851724 DOI: 10.1007/s11605-007-0239-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
86 Son T, Hyung WJ, Kim JW, Kim HI, An JY, Cheong JH, Choi SH, Noh SH. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. Ann Surg Oncol 2014;21:899-907. [PMID: 24276641 DOI: 10.1245/s10434-013-3403-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
87 Pyo JS, Kim JH, Lee SY, Baek TH, Kang DW. Metastatic Lymph Node Ratio (mLNR) is a Useful Parameter in the Prognosis of Colorectal Cancer; A Meta-Analysis for the Prognostic Role of mLNR. Medicina (Kaunas). 2019;55:673. [PMID: 31590275 DOI: 10.3390/medicina55100673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
88 Wang X, Appleby DH, Zhang X, Gan L, Wang JJ, Wan F. Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancer. Br J Surg. 2013;100:505-514. [PMID: 23319421 DOI: 10.1002/bjs.9014] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 4.6] [Reference Citation Analysis]
89 Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol. 2007;14:1712-1717. [PMID: 17253102 DOI: 10.1245/s10434-006-9322-3] [Cited by in Crossref: 140] [Cited by in F6Publishing: 138] [Article Influence: 9.3] [Reference Citation Analysis]
90 Toiyama Y, Fujikawa H, Koike Y, Saigusa S, Inoue Y, Tanaka K, Mohri Y, Miki C, Kusunoki M. Evaluation of preoperative C-reactive protein aids in predicting poor survival in patients with curative colorectal cancer with poor lymph node assessment. Oncol Lett 2013;5:1881-8. [PMID: 23833661 DOI: 10.3892/ol.2013.1308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
91 Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol. 2008;34:771-775. [PMID: 18079086 DOI: 10.1016/j.ejso.2007.11.002] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 3.0] [Reference Citation Analysis]
92 Noura S, Ohue M, Kano S, Shingai T, Yamada T, Miyashiro I, Ohigashi H, Yano M, Ishikawa O. Impact of metastatic lymph node ratio in node-positive colorectal cancer. World J Gastrointest Surg 2010; 2(3): 70-77 [PMID: 21160853 DOI: 10.4240/wjgs.v2.i3.70] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
93 Dekker JW, Peeters KC, Putter H, Vahrmeijer AL, van de Velde CJ. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol. 2010;36:1180-1186. [PMID: 20884164 DOI: 10.1016/j.ejso.2010.09.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
94 Tu RH, Lin JX, Wang W, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Zhou ZW, Zheng CH, Huang CM. Prognostic value of a new staging system based on the retrieved number and metastatic rate of LNs in gastric cancer with ≤15 retrieved LNs. Eur J Surg Oncol 2020;46:2221-8. [PMID: 32859432 DOI: 10.1016/j.ejso.2020.07.001] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
95 Yang Y, Zheng J, Li Y. Comparison of 4 lymph node staging systems for the prognostic prediction of esophagogastric junction adenocarcinoma with ≤15 retrieved lymph nodes. Eur J Surg Oncol 2021:S0748-7983(21)00942-2. [PMID: 34876328 DOI: 10.1016/j.ejso.2021.11.133] [Reference Citation Analysis]
96 Ebrahimi A, Clark JR, Zhang WJ, Elliott MS, Gao K, Milross CG, Shannon KF. Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma. Head Neck 2011;33:1245-51. [PMID: 20967874 DOI: 10.1002/hed.21600] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 6.2] [Reference Citation Analysis]
97 Wang P, Xiao F, Gong B, Liu F, Xu H. A Nomogram for Predicting Overall Survival of Gastric Cancer Patients with Insufficient Lymph Nodes Examined. J Gastrointest Surg 2017;21:947-56. [DOI: 10.1007/s11605-017-3401-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
98 Qiu C, Dong W, Su B, Liu Q, Du J. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer. J Thorac Oncol 2013;8:429-35. [PMID: 23486264 DOI: 10.1097/JTO.0b013e3182829c16] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
99 Rosa F, Tortorelli AP, Alfieri S, Doglietto GB. Lymph node ratio for gastric cancer: useful instrument or just an expedient to retrieve fewer lymph nodes? Ann Surg 2014;259:e65. [PMID: 24169197 DOI: 10.1097/SLA.0000000000000316] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
100 Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, Xu Y, Wang ZN, Xu HM. A novel subclassification of pT2 gastric cancers according to the depth of muscularis propria invasion: superficial muscularis propria versus deep muscularis propria/subserosa. Ann Surg 2009;249:768-75. [PMID: 19387327 DOI: 10.1097/SLA.0b013e3181a3df77] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
101 Wang J, Hassett JM, Dayton MT, Kulaylat MN. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15:1600-1608. [PMID: 18327530 DOI: 10.1245/s10434-007-9716-x] [Cited by in Crossref: 127] [Cited by in F6Publishing: 130] [Article Influence: 9.1] [Reference Citation Analysis]
102 Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB, Dayton M. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249:559-563. [PMID: 19300237 DOI: 10.1097/sla.0b013e318197f2c8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
103 Manilich EA, Kiran RP, Radivoyevitch T, Lavery I, Fazio VW, Remzi FH. A novel data-driven prognostic model for staging of colorectal cancer. J Am Coll Surg 2011; 213: 579-588, 588.e1-588. e2. [PMID: 21925905 DOI: 10.1016/j.jamcollsurg.2011.08.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
104 Schumacher P, Dineen S, Barnett C, Fleming J, Anthony T. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007;194:827-831; discussion 831-832. [PMID: 18005779 DOI: 10.1016/j.amjsurg.2007.08.030] [Cited by in Crossref: 88] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
105 Lee YC, Yang PJ, Zhong Y, Clancy TE, Lin MT, Wang J. Lymph Node Ratio-based Staging System Outperforms the Seventh AJCC System for Gastric Cancer: Validation Analysis With National Taiwan University Hospital Cancer Registry. Am J Clin Oncol 2017;40:35-41. [PMID: 25089533 DOI: 10.1097/COC.0000000000000110] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
106 Xu DZ, Geng QR, Long ZJ, Zhan YQ, Li W, Zhou ZW, Chen YB, Sun XW, Chen G, Liu Q. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol. 2009;16:319-326. [PMID: 19050970 DOI: 10.1245/s10434-008-0240-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 79] [Article Influence: 5.1] [Reference Citation Analysis]
107 Melis M, Masi A, Pinna A, Cohen S, Hatzaras I, Berman R, Pachter LH, Newman E. Does lymph node ratio affect prognosis in gastroesophageal cancer? The American Journal of Surgery 2015;210:443-50. [DOI: 10.1016/j.amjsurg.2014.12.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
108 Wang W, Xu D, Li Y, Guan Y, Sun X, Chen Y, Kesari R, Huang C, Li W, Zhan Y, Zhou Z. Tumor–ratio–metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection—results of a single-institution study of 1343 Chinese patients. Annals of Oncology 2011;22:2049-56. [DOI: 10.1093/annonc/mdq716] [Cited by in Crossref: 54] [Cited by in F6Publishing: 65] [Article Influence: 4.9] [Reference Citation Analysis]
109 Jiang T, Huang C, Xu Y, Su Y, Zhang G, Xie L, Huang L, You S, Zha J. Ratio of positive lymph nodes: The prognostic value in stage IV thyroid cancer. Oncotarget 2017;8:79462-8. [PMID: 29108325 DOI: 10.18632/oncotarget.18402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
110 Mohan HM, Walsh C, Kennelly R, Ng CH, O'Connell PR, Hyland JM, Hanly A, Martin S, Gibbons D, Sheahan K, Winter DC. The lymph node ratio does not provide additional prognostic information compared with the N1/N2 classification in Stage III colon cancer. Colorectal Dis 2017;19:165-71. [PMID: 27317165 DOI: 10.1111/codi.13410] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
111 Lee H, Kong S, Yang H. Reply to: Discussion of the Applicability of Positive Lymph Node Ratio as a Proper N-Staging for Predication the Prognosis of Gastric Cancer After Curative Surgery Plus Extended Lymphadenectomy. Annals of Surgery 2012;256:e37-8. [DOI: 10.1097/sla.0b013e3182769559] [Reference Citation Analysis]
112 Rodríguez Santiago J, Muñoz E, Martí M, Quintana S, Veloso E, Marco C. Metastatic lymph node ratio as a prognostic factor in gastric cancer. European Journal of Surgical Oncology (EJSO) 2005;31:59-66. [DOI: 10.1016/j.ejso.2004.09.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 3.6] [Reference Citation Analysis]
113 Persiani R, Rausei S, Antonacci V, Biondi A, Casella F, Ciccoritti L, D’ugo D. Metastatic Lymph Node Ratio: A New Staging System for Gastric Cancer. World J Surg 2009;33:2106-11. [DOI: 10.1007/s00268-009-0157-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
114 Zhang H, Wang W, Diao D, Cheng Y, Song Y, Zhu K, Dang C. Ratio of metastatic to examined lymph nodes, a helpful staging system and independent prognostic factor of esophagogastric junction cancer. PLoS One. 2013;8:e73238. [PMID: 23977381 DOI: 10.1371/journal.pone.0073238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
115 Pedrazzani C, Sivins A, Ancans G, Marrelli D, Corso G, Krumins V, Roviello F, Leja M. Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: results from a single-center experience of 526 patients. World J Surg. 2010;34:85-91. [PMID: 20020295 DOI: 10.1007/s00268-009-0288-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
116 Jiang K, Zhu Y, Liu Y, Ye Y, Xie Q, Yang X, Wang S. Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examined. Tumor Biol 2014;35:11685-90. [DOI: 10.1007/s13277-014-2484-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
117 Zurleni T, Gjoni E, Ballabio A, Casieri R, Ceriani P, Marzoli L, Zurleni F. Sixth and seventh tumor-node-metastasis staging system compared in gastric cancer patients. World Journal of Gastrointestinal Surgery 2013; 5(11): 287-293 [PMID: 24520426 DOI: 10.4240/wjgs.v5.i11.287] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
118 Greenberg R, Itah R, Ghinea R, Sacham-shmueli E, Inbar R, Avital S. Metastatic lymph node ratio (LNR) as a prognostic variable in colorectal cancer patients undergoing laparoscopic resection. Tech Coloproctol 2011;15:273-9. [DOI: 10.1007/s10151-011-0701-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
119 Martinez-Ramos D, Calero A, Escrig-Sos J, Mingol F, Daroca-Jose JM, Sauri M, Arroyo A, Salvador-Sanchis JL, de Juan M, Calpena R, Lacueva FJ. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes. Eur J Surg Oncol 2014;40:358-65. [PMID: 24075824 DOI: 10.1016/j.ejso.2013.08.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
120 Gleisner AL, Mogal H, Dodson R, Efron J, Gearhart S, Wick E, Lidor A, Herman JM, Pawlik TM. Nodal status, number of lymph nodes examined, and lymph node ratio: what defines prognosis after resection of colon adenocarcinoma? J Am Coll Surg. 2013;217:1090-1100. [PMID: 24045143 DOI: 10.1016/j.jamcollsurg.2013.07.404] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 4.7] [Reference Citation Analysis]
121 Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience. Ann Surg Oncol 2003;10:1077-85. [DOI: 10.1245/aso.2003.03.520] [Cited by in Crossref: 136] [Cited by in F6Publishing: 61] [Article Influence: 7.2] [Reference Citation Analysis]
122 Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15:165-174. [PMID: 17896141 DOI: 10.1245/s10434-007-9587-1] [Cited by in Crossref: 264] [Cited by in F6Publishing: 256] [Article Influence: 17.6] [Reference Citation Analysis]
123 Ke B, Song XN, Liu N, Zhang RP, Wang CL, Liang H. Prognostic value of the lymph node ratio in stage III gastric cancer patients undergoing radical resection. PLoS One. 2014;9:e96455. [PMID: 24811256 DOI: 10.1371/journal.pone.0096455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
124 Costi R, Beggi F, Reggiani V, Riccò M, Crafa P, Bersanelli M, Tartamella F, Violi V, Roncoroni L, Sarli L. Lymph Node Ratio Improves TNM and Astler-Coller’s Assessment of Colorectal Cancer Prognosis: an Analysis of 761 Node Positive Cases. J Gastrointest Surg 2014;18:1824-36. [DOI: 10.1007/s11605-014-2591-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
125 Maduekwe UN, Lauwers GY, Fernandez-Del-Castillo C, Berger DL, Ferguson CM, Rattner DW, Yoon SS. New metastatic lymph node ratio system reduces stage migration in patients undergoing D1 lymphadenectomy for gastric adenocarcinoma. Ann Surg Oncol. 2010;17:1267-1277. [PMID: 20099040 DOI: 10.1245/s10434-010-0914-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 3.5] [Reference Citation Analysis]
126 Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging. Ann Surg. 2012;255:50-58. [PMID: 21577089 DOI: 10.1097/sla.0b013e31821d4d75] [Cited by in Crossref: 94] [Cited by in F6Publishing: 45] [Article Influence: 9.4] [Reference Citation Analysis]
127 Zhou Y, Zhang J, Cao S, Li Y. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309-317. [PMID: 22945599 DOI: 10.1007./s10120-012-0190-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
128 Deng J, Liang H, Wang D, Sun D, Ding X, Pan Y, Liu X. Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol. 2010;17:1043-1051. [PMID: 20039218 DOI: 10.1245/s10434-009-0863-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 56] [Article Influence: 3.7] [Reference Citation Analysis]
129 Lorenzen S, Blank S, Lordick F, Siewert JR, Ott K. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients. Ann Surg Oncol. 2012;19:2119-2127. [PMID: 22395980 DOI: 10.1245/s10434-012-2254-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 3.6] [Reference Citation Analysis]
130 Zhang J, Niu Z, Zhou Y, Cao S. A comparison between the seventh and sixth editions of the American Joint Committee on Cancer/International Union Against classification of gastric cancer. Ann Surg. 2013;257:81-86. [PMID: 23059507 DOI: 10.1097/sla.0b013e31825eff3f] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
131 Douglass HO. Gastric cancer: D2 all over again. Ann Surg Oncol 2003;10:206-7. [PMID: 12679301 DOI: 10.1245/aso.2003.01.015] [Reference Citation Analysis]
132 Xiao C, Song B, Yi P, Xie Y, Li B, Lian P, Ding S, Lu Y. Deaths of colon neuroendocrine tumors are associated with increasing metastatic lymph nodes and lymph node ratio. J Gastrointest Oncol 2020;11:1146-54. [PMID: 33456989 DOI: 10.21037/jgo-20-444] [Reference Citation Analysis]
133 Chae S, Lee A, Lee JH. The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification. Gastric Cancer. 2011;14:166-171. [PMID: 21360132 DOI: 10.1007/s10120-011-0024-6] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 5.5] [Reference Citation Analysis]
134 Costa ML, de Cássia Braga Ribeiro K, Machado MA, Costa AC, Montagnini AL. Prognostic score in gastric cancer: the importance of a conjoint analysis of clinical, pathologic, and therapeutic factors. Ann Surg Oncol 2006;13:843-50. [PMID: 16614885 DOI: 10.1245/ASO.2006.05.040] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
135 Calero A, Escrig-Sos J, Mingol F, Arroyo A, Martinez-Ramos D, de Juan M, Salvador-Sanchis JL, Garcia-Granero E, Calpena R, Lacueva FJ. Usefulness of the log odds of positive lymph nodes to predict and discriminate prognosis in gastric carcinomas. J Gastrointest Surg 2015;19:813-20. [PMID: 25560183 DOI: 10.1007/s11605-014-2728-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
136 Gu P, Deng J, Sun Z, Wang Z, Wang W, Liang H, Xu H, Zhou Z. Superiority of log odds of positive lymph nodes (LODDS) for prognostic prediction after gastric cancer surgery: a multi-institutional analysis of 7620 patients in China. Surg Today 2021;51:101-10. [PMID: 32754844 DOI: 10.1007/s00595-020-02091-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
137 Yuan RH, Wang CC, Chou CC, Chang KJ, Lee PH, Jeng YM. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma. Ann Surg Oncol 2009;16:1711-9. [PMID: 19357927 DOI: 10.1245/s10434-009-0446-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
138 Persiani R, Rausei S, Biondi A, Boccia S, Cananzi F, D'Ugo D. Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 2008;34:519-24. [PMID: 17624713 DOI: 10.1016/j.ejso.2007.05.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
139 Song W, Yuan Y, Wang L, He W, Zhang X, Chen C, Zhang C, Cai S, He Y. The prognostic value of lymph nodes dissection number on survival of patients with lymph node-negative gastric cancer. Gastroenterol Res Pract. 2014;2014:603194. [PMID: 24868201 DOI: 10.1155/2014/603194] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
140 Chin KM, Di Martino M, Syn N, Ielpo B, Hilal MA, Goh BKP, Koh YX, Prieto M. Re-appraising the role of lymph node status in predicting survival in resected distal cholangiocarcinoma - A meta-analysis and systematic review. Eur J Surg Oncol 2021;47:1267-77. [PMID: 33549378 DOI: 10.1016/j.ejso.2021.01.004] [Reference Citation Analysis]
141 Tayyab M, Sharma A, Macdonald AW, Gunn J, Hartley JE, Monson JR. Prognostic significance of lymph node ratio in patients undergoing abdominoperineal resection of rectum. Langenbecks Arch Surg. 2012;397:1053-1057. [PMID: 22875223 DOI: 10.1007/s00423-012-0986-9] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
142 Zhou Z, Xie X, Hao N, Diao D, Song Y, Xia P, Dang C, Zhang H. Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction. Curr Med Res Opin 2018;34:963-70. [PMID: 29338535 DOI: 10.1080/03007995.2018.1429390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
143 Petrelli F, Borgonovo K, Barni S. The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: An overview of literature. European Journal of Surgical Oncology (EJSO) 2011;37:836-47. [DOI: 10.1016/j.ejso.2011.07.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
144 Hurtuk MG, Hughes C, Shoup M, Aranha GV. Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg. 2009;197:348-352. [PMID: 19245913 DOI: org/10.1016/j.amjsurg.2008.11.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
145 Xu J, Bian YH, Jin X, Cao H. Prognostic assessment of different metastatic lymph node staging methods for gastric cancer after D2 resection. World J Gastroenterol 2013; 19(12): 1975-1983 [PMID: 23569344 DOI: 10.3748/wjg.v19.i12.1975] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
146 Kim CY, Yang DH. Adjustment of N stages of gastric cancer by the ratio between the metastatic and examined lymph nodes. Ann Surg Oncol. 2009;16:1868-1874. [PMID: 19434459 DOI: 10.1245/s10434-009-0430-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
147 Chen Y, Li C, Du Y, Xu Q, Ying J, Luo C. Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection. Oncotarget 2017;8:70841-6. [PMID: 29050324 DOI: 10.18632/oncotarget.19998] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
148 Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215 [PMID: 23444312 DOI: 10.4251/wjgo.v4.i10.207] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
149 Sianesi M, Bezer L, Del Rio P, Dell’Abate P, Iapichino G, Soliani P, Tacci S. The node ratio as prognostic factor after curative resection for gastric cancer. J Gastrointest Surg. 2010;14:614-619. [PMID: 20101526 DOI: 10.1007/s11605-009-1142-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
150 Priolli DG, Cardinalli IA, Pereira JA, Alfredo CH, Margarido NF, Martinez CA. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol. 2009;13:113-121. [PMID: 19484349 DOI: 10.1007/s10151-009-0467-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
151 Attaallah W, Uprak K, Gunal O, Yegen C. Prognostic Impact of the Metastatic Lymph Node Ratio on Survival in Gastric Cancer. Indian J Surg Oncol 2016;7:67-72. [PMID: 27065685 DOI: 10.1007/s13193-016-0490-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
152 Zhu J, Xue Z, Zhang S, Guo X, Zhai L, Shang S, Zhang Y, Lu H. Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis. Int J Surg 2018;57:76-83. [PMID: 30103072 DOI: 10.1016/j.ijsu.2018.08.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
153 Sun Z, Zhu GL, Lu C, Guo PT, Huang BJ, Li K, Xu Y, Li DM, Wang ZN, Xu HM. The impact of N-ratio in minimizing stage migration phenomenon in gastric cancer patients with insufficient number or level of lymph node retrieved: results from a Chinese mono-institutional study in 2159 patients. Ann Oncol. 2009;20:897-905. [PMID: 19179553 DOI: 10.1093/annonc/mdn707] [Cited by in Crossref: 71] [Cited by in F6Publishing: 87] [Article Influence: 5.5] [Reference Citation Analysis]
154 Wang H, Xing XM, Ma LN, Liu L, Hao J, Feng LX, Yu Z. Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer. Oncol Lett 2018;15:8853-62. [PMID: 29844813 DOI: 10.3892/ol.2018.8497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
155 Pedrazzani C, de Manzoni G, Marrelli D, Giacopuzzi S, Corso G, Bernini M, Roviello F. Nodal Staging in Adenocarcinoma of the Gastro-Esophageal Junction. Proposal of a Specific Staging System. Ann Surg Oncol 2007;14:299-305. [DOI: 10.1245/s10434-006-9094-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
156 Mann GB. Gastric cancer. ANZ J Surg 2004;74:827-8. [PMID: 15456421 DOI: 10.1111/j.1445-1433.2004.03240.x] [Reference Citation Analysis]
157 Konstantinidis IT, Deshpande V, Zheng H, Wargo JA, Fernandez-del Castillo C, Thayer SP, Androutsopoulos V, Lauwers GY, Warshaw AL, Ferrone CR. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? J Gastrointest Surg 2010;14:261-7. [PMID: 19937477 DOI: 10.1007/s11605-009-1096-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
158 Lu YJ, Lin PC, Lin CC, Wang HS, Yang SH, Jiang JK, Lan YT, Lin TC, Liang WY, Chen WS. The impact of the lymph node ratio is greater than traditional lymph node status in stage III colorectal cancer patients. World J Surg. 2013;37:1927-1933. [PMID: 23609344 DOI: 10.1007/s00268-0132051-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Cannon RM, LeGrand R, Chagpar RB, Ahmad SA, McClaine R, Kim HJ, Rupp C, Cho CS, Brinkman A, Weber S. Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection. HPB (Oxford). 2012;14:228-235. [PMID: 22404260 DOI: 10.1111/j.1477-2574.2011.00432.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
160 Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W, Cai S. Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer. Ann Surg Oncol 2008;15:3118-23. [DOI: 10.1245/s10434-008-0123-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 3.4] [Reference Citation Analysis]
161 Shin S, Kang D, Cho JH, Choi YS, Kim J, Zo JI, Shim YM, Kim HK. Prognostic impact of lymph node ratio in patients with pT1-2N1M0 non-small cell lung cancer. J Thorac Dis 2020;12:5552-60. [PMID: 33209388 DOI: 10.21037/jtd-20-1611] [Reference Citation Analysis]
162 Medani M, Kelly N, Samaha G, Duff G, Healy V, Mulcahy E, Condon E, Waldron D, Saunders J, Coffey JC. An appraisal of lymph node ratio in colon and rectal cancer: not one size fits all. Int J Colorectal Dis. 2013;28:1377-1384. [PMID: 23715847 DOI: 10.1007/s00384-013-1707-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
163 Kimbrough CW, St Hill CR, Martin RC, McMasters KM, Scoggins CR. Tumor-positive resection margins reflect an aggressive tumor biology in pancreatic cancer. J Surg Oncol. 2013;107:602-607. [PMID: 23450687 DOI: 10.1002/jso.23299] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
164 Xiao LB, Yu JX, Wu WH, Xu FF, Yang SB. Superiority of metastatic lymph node ratio to the 7th edition UICC N staging in gastric cancer. World J Gastroenterol 2011; 17(46): 5123-5130 [PMID: 22171148 DOI: 10.3748/wjg.v17.i46.5123] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
165 Wang X, Wan F, Wang J. A Common Misuse of Stepwise Regression in Studies of Ratio of Metastatic Lymph Nodes for Gastric Cancer. Ann Surg Oncol 2008;15:1805-6. [DOI: 10.1245/s10434-008-9908-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
166 Choi BG, Kim CY, Cho SH, Kim HJ, Koh YS, Kim JC, Cho CK, Kim HJ, Hur YH. Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc. 2013;84:168-177. [PMID: 23487246 DOI: 10.4174/jkss.2013.84.3.168] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
167 Wo Y, Li S, Wang Y, Lu T, Qin Y, Sun X, Jiao W. Predictors of nodal metastasis and prognostic significance of lymph node ratio and total lymph node count in tracheobronchial adenoid cystic carcinoma. Cancer Manag Res 2018;10:5919-25. [PMID: 30510459 DOI: 10.2147/CMAR.S182069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol. 2007;96:95-101. [PMID: 17443727 DOI: 10.1002/jso.20797] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 3.2] [Reference Citation Analysis]
169 Fukuda N. Moving from lymph node metastasis in gastric cancer to biological markers: reply to letter. World J Surg 2010;34:1142-3. [PMID: 20155265 DOI: 10.1007/s00268-010-0461-0] [Reference Citation Analysis]
170 Mckee MD, Posner MC. The Staging of Gastric Cancer: Nothing Novel but Perhaps Better. Ann Surg Oncol 2003;10:1005-6. [DOI: 10.1245/aso.2003.09.914] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
171 Cheong JH, Hyung WJ, Shen JG, Song C, Kim J, Choi SH, Noh SH. The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol. 2006;13:377-385. [PMID: 16450215 DOI: 10.1245/aso.2006.04.018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
172 Zhang M, Ding C, Xu L, Ou B, Feng S, Wang G, Wang W, Liang Y, Chen Y, Zhou Z, Qiu H. Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer. Front Oncol 2021;11:595421. [PMID: 34307116 DOI: 10.3389/fonc.2021.595421] [Reference Citation Analysis]
173 Kim YS, Kim JH, Yoon SM, Choi EK, Ahn SD, Lee SW, Kim JC, Yu CS, Kim HC, Kim TW. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;74:796-802. [PMID: 19289261 DOI: 10.1016/j.ijrobp.2008.08.065] [Cited by in Crossref: 55] [Cited by in F6Publishing: 60] [Article Influence: 4.2] [Reference Citation Analysis]
174 Ozmen MM, Zulfikaroglu B, Ozmen F, Moran M, Ozalp N, Seckin S. D2 vs D2 Plus Para-aortic Lymph Node Dissection for Advanced Gastric Cancer. Turk J Surg 2021;37:49-58. [PMID: 34585094 DOI: 10.47717/turkjsurg.2020.4931] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
175 Ema A, Yamashita K, Sakuramoto S, Wang G, Mieno H, Nemoto M, Shibata T, Katada N, Kikuchi S, Watanabe M. Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy. Gastric Cancer. 2014;17:67-75. [PMID: 23801337 DOI: 10.1007/s10120-013-0253-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
176 Hurtuk MG, Hughes C, Shoup M, Aranha GV. Does lymph node ratio impact survival in resected periampullary malignancies? Am J Surg 2009;197:348-52. [PMID: 19245913 DOI: 10.1016/j.amjsurg.2008.11.010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.1] [Reference Citation Analysis]
177 Wu XJ, Miao RL, Li ZY, Bu ZD, Zhang LH, Wu AW, Zong XL, Li SX, Shan F, Ji X. Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer. Eur J Surg Oncol. 2015;41:927-933. [PMID: 25913059 DOI: 10.1016/j.ejso.2015.03.225] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
178 Medina-franco H, Cabrera-mendoza F, Almaguer-rosales S, Guillén F, Suárez-bobadilla YL, Sánchez-ramón A. Lymph Node Ratio as a Predictor of Survival in Gastric Carcinoma. The American Surgeon 2013;79:284-9. [DOI: 10.1177/000313481307900328] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
179 Hong SA, Son MW, Cho J, Lee CH, Jang SH, Lee HJ, Lee JH, Cho HD, Oh MH, Lee KT, Lee MS. Prognostic value of fibrosis ratio in metastatic lymph nodes of node-positive advanced gastric cancer. Medicine (Baltimore) 2018;97:e9703. [PMID: 29505025 DOI: 10.1097/MD.0000000000009703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Zhang M, Zhu G, Ma Y, Xue Y. Comparison of four staging systems of lymph node metastasis in gastric cancer. World J Surg. 2009;33:2383-2388. [PMID: 19760313 DOI: 10.1007/s00268-009-0214-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
181 Zhou Y, Zhang J, Cao S, Li Y. The evaluation of metastatic lymph node ratio staging system in gastric cancer. Gastric Cancer. 2013;16:309-317. [PMID: 22945599 DOI: 10.1007/s10120-012-0190-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
182 Jiang J, Chen J, Zhang H, Rao X, Hao T, Li M, Zhang C, Wu W, He Y. Combination of the ratio between metastatic and harvested lymph nodes and negative lymph node count as a prognostic indicator in advanced gastric cancer: a retrospective cohort study. J Gastrointest Oncol 2021;12:2022-34. [PMID: 34790370 DOI: 10.21037/jgo-21-212] [Reference Citation Analysis]